FIELD: organic chemistry.
SUBSTANCE: invention relates to organic chemistry, namely to the use of indole-3-carboxylic acid derivatives of structural formulas (1), (2), (3) as water-soluble immunomodulatory antitumor agents. Doses of the active substance can range from 20 to 100 mg/kg.
EFFECT: water-soluble immunomodulatory antitumor agent creation.
2 cl, 6 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TARGETED THERAPY OF MALIGNANT GROWTHS | 2018 |
|
RU2699558C2 |
COMPLEX ANTI-TUMORAL PRODUCT | 2020 |
|
RU2751776C2 |
STABILIZED COMPOSITION POSSESSING ANTIVIRAL, ANTICANCER, IMMUNOMODULATORY, ACTOPROTECTIVE, ANTIMUTAGENIC AND ANTIOXIDANT ACTIVITY | 2018 |
|
RU2690677C1 |
COMPLEX ANTIANGIOGENIC AND HYPOXIA-TARGETED ANTITUMOR AGENT | 2022 |
|
RU2804771C1 |
AGENT WITH ANTITUMOUR AND ANTIMETASTATIC ACTIVITY, ANTI-INFLAMMATORY AND ANTIALLERGIC ACTION | 2018 |
|
RU2686672C1 |
SET OF DRUGS FOR CONDUCTING A COURSE OF TERTIARY PREVENTION OF ONCOLOGICAL DISEASES FOR IMMUNOMODULATORY EFFECTS IN COMBINATION THERAPY AND A METHOD FOR TERTIARY PREVENTION OF ONCOLOGICAL DISEASES USING COMBINATION THERAPY USING A SET OF DRUGS FOR IMMUNOMODULATING EFFECTS | 2022 |
|
RU2794024C1 |
TUMOUR THERAPY AGENT | 2019 |
|
RU2726801C1 |
METHOD OF TREATING MELANOMA IN VIVO | 2023 |
|
RU2824428C2 |
METHOD FOR ACHIEVING ANTIMETASTATIC EFFECT IN EXPERIMENT | 2017 |
|
RU2661704C1 |
IMMUNOMODULATOR WITH ANTITUMOR ACTIVITY AND DRUG BASED ON THE SAME | 2005 |
|
RU2283663C1 |
Authors
Dates
2022-11-07—Published
2022-05-05—Filed